TORONTO, July 10, 2018 (GLOBE NEWSWIRE) — WeedMD Inc. (WMD.V) (WDDMF) (4WE.F) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, announces that it has agreed with Hiku Brands Company Ltd. (“Hiku”) to terminate the previously announced Arrangement Agreement, dated April 19, 2018 (“Arrangement Agreement”). In connection with the termination of the Arrangement Agreement, the Company has received a $10 million termination fee. WeedMD is also pleased to announce that it has appointed Keith Merker, currently Chief Financial Officer, to the position of Chief Executive Officer, effective immediately.

“Over the past year, WeedMD has executed on our growth strategy and we continue moving forward with our strategic plan,” said Keith Merker, Chief Executive Officer of WeedMD. “In the past quarter, we’ve built out our management team, licensed and commissioned our state-of-the-art greenhouse expansion (link), signed a supply agreement with Shoppers Drug Mart (link) and secured a supply agreement with the Alberta Gaming, Liquor and Cannabis Commission (link). With an additional $10 million in non-dilutive capital and over $50 million in cash, all of our commitments are fully funded and we’re in a solid position financially and operationally to continue executing and delivering on all of our goals and objectives.”

With the appointment of Keith Merker as CEO of the Company, former CEO Bruce Dawson-Scully will take on an advisory role to ensure an orderly transition. WeedMD and its Board of Directors wishes to thank Bruce for his visionary insights into the seniors’ care market and his stalwart dedication to launching WeedMD from a private, early-stage Health Canada applicant to a public company with two operational facilities and an industry-leading medical platform.

The Company is also pleased to announce that Nichola Thompson will take on the role of interim CFO. Nichola currently serves as WeedMD’s Director of Finance and has previously held management positions in finance with Discovery Air, Deloitte & Touche and Siemens.

Additional management appointments will be announced in the coming weeks.

WeedMD’s Annual Shareholder Meeting will take place as scheduled on Wednesday, July 11, 2018 at 10:00 a.m. (Toronto time) at Fogler, Rubinoff LLP, located at TD Centre North Tower, Suite 3000, 77 King Street, Toronto, Ontario.

For more information, access our updated investor presentation here and corporate video here.

About WeedMD Inc.

WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of medical cannabis and oils under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates a 26,000 sq. ft. indoor facility in Aylmer, Ontario, and a second cultivation site at its greenhouse facility located in Strathroy, Ontario, representing 610,000 sq. ft. or 14 acres under glass. WeedMD has entered into supply agreements in addition to strategic relationships with established cannabis brands. WeedMD is focused on providing medical cannabis to the seniors’ markets in Canada through its proprietary seniors care program. It is dedicated to educating healthcare practitioners and furthering public understanding of the role that medical cannabis plays – including as it pertains to regulatory requirements, indications and potential side effects.

Follow WeedMD On:

Facebook: https://www.facebook.com/weedmd/ 
LinkedIn: https://www.linkedin.com/company-beta/5020743/ 
Twitter: https://twitter.com/WeedMD 
Instagram: https://www.instagram.com/weedmd/ 

For further information, please contact:

WeedMD Inc.

Keith Merker, Chief Executive Officer
Tel: 519-765-2440 Ext. 222
Email: investor@weedmd.com

To learn more, visit us at www.weedmd.com

For Media Inquiries:

Marianella delaBarrera
Margin Communications & Public Relations
Tel: 416-897-6644
Email: marianella@marginpr.com

Cautionary Statement on Forward-Looking Information